The codons found in the KRAS gene, in contrast to those in HRAS, have been selected for low protein expression, and it has been hypothesized that KRAS cancers may be more common because low expression of mutant KRAS protein promotes hyperplasia but not senescence [25–27], allowing additional mutations to be accumulated on the path to cancer. This evidence concerns the gene KRAS and cancer.